Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Thomas Barratt
Observed names:
D BARRATT,
D. T. Barratt,
D.T. Barratt,
DT Barratt,
Daniel Barratt,
Daniel T Barratt,
Daniel T. Barratt
show all 7
Institutions:
ARC Centre for Nanoscale BioPhotonics,
Adelaide University,
The University of Adelaide
Observed institutions:
University of Copenhagen,
Royal Adelaide Hospital,
Norwegian University of Science and Technology,
ARC Centre for Nanoscale BioPhotonics,
Adelaide University,
The University of Adelaide
show all 6
ORCID:
0000-0001-6261-353X
Observed ORCID:
0000-0001-6261-353X
OpenAlex ID:
A5077900083
Pharmacogenetics of Opioids
2007
·
Andrew A Somogyi
, Daniel T Barratt
, et al.
·
Clinical Pharmacology & Therapeutics
·
328
Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factors
2018
·
D.A. Rice
, M.T. Kluger
, et al.
·
British Journal of Anaesthesia
·
178
PDF
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
2006
·
J COLLER
, D BARRATT
, et al.
·
Clinical Pharmacology & Therapeutics
·
150
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments
2006
·
Daniel T. Barratt
, Janet K. Coller
, et al.
·
American Journal of Medical Genetics Part B Neuropsychiatric Genetics
·
94
B cells drive neuropathic pain–related behaviors in mice through IgG–Fc gamma receptor signaling
2024
·
Michael J. Lacagnina
, Kendal F. Willcox
, et al.
·
Science Translational Medicine
·
69
PDF
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
2014
·
Daniel T. Barratt
, Benedikte Bandak
, et al.
·
Pharmacogenetics and Genomics
·
55
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics
2012
·
Daniel Barratt
, Janet Coller
, et al.
·
Pharmacogenomics and Personalized Medicine
·
50
PDF
Pharmacogenomics of Methadone Maintenance Treatment
2014
·
Andrew A Somogyi
, Daniel T Barratt
, et al.
·
Pharmacogenomics
·
48
CYP3A5*3andABCB161A>G Significantly Influence Dose‐adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post‐Kidney Transplantation
2018
·
Rong Hu
, Daniel T. Barratt
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
39
Pharmacogenetics of Opioid Response
2014
·
AA Somogyi
, JK Coller
, et al.
·
Clinical Pharmacology & Therapeutics
·
37
Harnessing pain heterogeneity and RNA transcriptome to identify blood‐based pain biomarkers: a novel correlational study design and bioinformatics approach in a graded chronic constriction injury model
2012
·
Peter M. Grace
, Daniel Hurley
, et al.
·
Journal of Neurochemistry
·
34
Corticosterone Preexposure Increases NF-κB Translocation and Sensitizes IL-1β Responses in BV2 Microglia-Like Cells
2018
·
JiaJun Liu
, Sanam Mustafa
, et al.
·
Frontiers in Immunology
·
32
Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction and Sickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl
2015
·
Daniel T. Barratt
, Pål Klepstad
, et al.
·
PLoS ONE
·
32
PDF
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression
2022
·
Ahmad Y. Abuhelwa
, Andrew A. Somogyi
, et al.
·
Clinical Pharmacology & Therapeutics
·
30
PDF
Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative pain
2016
·
Andrew A. Somogyi
, Alex T. Sia
, et al.
·
Pain
·
28
Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients
2021
·
Benedetta C. Sallustio
, Benjamin D. Noll
, et al.
·
British Journal of Clinical Pharmacology
·
25
High and variable population prevalence of HLA‐B*56:02 in indigenous Australians and relation to phenytoin‐associated drug reaction with eosinophilia and systemic symptoms
2019
·
Andrew A. Somogyi
, Daniel T. Barratt
, et al.
·
British Journal of Clinical Pharmacology
·
24
CYP2C8 Genotype Significantly Alters Imatinib Metabolism in Chronic Myeloid Leukaemia Patients
2016
·
Daniel T. Barratt
, Hannah K. Cox
, et al.
·
Clinical Pharmacokinetics
·
23
Factors associated with persistent opioid use 6–12 months after primary total knee arthroplasty
2022
·
M. T. Kluger
, D. A. Rice
, et al.
·
Anaesthesia
·
21
PDF
Role of pharmacogenetics in personalised imatinib dosing
2017
·
Daniel T. Barratt
, Andrew A. Somogyi
·
Translational Cancer Research
·
19
Association of Innate Immune Single-Nucleotide Polymorphisms with the Electroencephalogram During Desflurane General Anaesthesia
2013
·
Claire Vignette Mulholland
, Andrew Alexander Somogyi
, et al.
·
Journal of Molecular Neuroscience
·
18
Impact ofCYP2C8*3polymorphism onin vitrometabolism of imatinib to N-desmethyl imatinib
2015
·
Muhammad Suleman Khan
, Daniel T. Barratt
, et al.
·
Xenobiotica
·
16
Biomarkers to predict, prevent, and treat persistent pain: omics
2025
·
Mark R. Hutchinson
, Daniel Barratt
, et al.
·
Pain
·
14
Effect of tacrolimus dispositional genetics on acute rejection in the first 2 weeks and estimated glomerular filtration rate in the first 3 months following kidney transplantation
2018
·
Rong Hu
, Daniel T. Barratt
, et al.
·
Pharmacogenetics and Genomics
·
11
New pharmacological perspectives and therapeutic options for opioids: Differences matter
2022
·
Andrew A Somogyi
, Stefan T Musolino
, et al.
·
Anaesthesia and Intensive Care
·
10
Show more works
View as search
Works count:
47
Citation count:
1,448
H-index:
19
I10-index:
25
Year
Topic
Type
